Strategic partnerships Leverage collaborations with universities and research institutes noted in recent news, such as the University of Derby collaboration, to offer joint development programs, licensing opportunities for PODS delivery systems, and outsourced EV analysis services to expand revenue streams.

Exosome leadership Capitalize on the strong focus in extracellular vesicle biology by targeting labs needing EV isolation, characterization and biomarker assays, using Exo-spin kits, EVlution systems, ExoLISA services, and MISEV-compliant analytics to upsell full-service EV workflows.

Therapeutic delivery Promote PODS sustained-release growth factors as a platform for in vitro and in vivo studies, targeting oncology, neuroscience, and regenerative medicine segments where prolonged local delivery is advantageous, and pursue joint studies or sponsored research with academic labs and biotech partners.

Smaller-firm agility Position as a nimble, cost-efficient collaborator for early-stage biotech and academic labs seeking specialized reagents, cytogenetics services, and bespoke research support, highlighting faster quote cycles and flexible service packages to win pilot projects.

Global reach Emphasize the Cambridge base with St. Louis offices to pursue cross-continental contracts, international grants, and turnkey outsourced EV characterization, offering scalable EV services and regional support that appeals to labs looking for reliable global partners.